[Costs of diseases with long-term survival].
Standard
[Costs of diseases with long-term survival]. / Brettschneider, Christian; Konnopka, Alexander; König, Hans-Helmut.
in: BUNDESGESUNDHEITSBLA, Jahrgang 55, Nr. 4, 4, 2012, S. 468-473.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - [Costs of diseases with long-term survival].
AU - Brettschneider, Christian
AU - Konnopka, Alexander
AU - König, Hans-Helmut
PY - 2012
Y1 - 2012
N2 - In the past decades medical progress in the treatment of fatal diseases has led to substantial improvement of survival. This long-term survival has financial consequences for health care and society. In this article methodological challenges of measuring the costs of long-term survival are presented. In this regard the costs of long-term treatment, indirect costs, unrelated future health care costs and discounting of costs are highlighted and illustrated by examples. A methodological challenge related to the economic evaluation of therapies leading to long-term survival is the consideration of unrelated future health care costs occurring in life years gained. In the literature the issue of unrelated future health care costs is discussed comprehensively on a methodological-theoretical basis. In economic evaluations published in the literature, these costs have rarely been considered so far, which may cause biased results. Concerning the comparability of study results, a standardization of the methods of measuring costs is desirable.
AB - In the past decades medical progress in the treatment of fatal diseases has led to substantial improvement of survival. This long-term survival has financial consequences for health care and society. In this article methodological challenges of measuring the costs of long-term survival are presented. In this regard the costs of long-term treatment, indirect costs, unrelated future health care costs and discounting of costs are highlighted and illustrated by examples. A methodological challenge related to the economic evaluation of therapies leading to long-term survival is the consideration of unrelated future health care costs occurring in life years gained. In the literature the issue of unrelated future health care costs is discussed comprehensively on a methodological-theoretical basis. In economic evaluations published in the literature, these costs have rarely been considered so far, which may cause biased results. Concerning the comparability of study results, a standardization of the methods of measuring costs is desirable.
KW - Humans
KW - Germany/epidemiology
KW - Health Care Costs/statistics & numerical data
KW - Mortality/trends
KW - Chronic Disease/economics/mortality
KW - Life Expectancy/trends
KW - Survivors/statistics & numerical data
KW - Humans
KW - Germany/epidemiology
KW - Health Care Costs/statistics & numerical data
KW - Mortality/trends
KW - Chronic Disease/economics/mortality
KW - Life Expectancy/trends
KW - Survivors/statistics & numerical data
M3 - SCORING: Zeitschriftenaufsatz
VL - 55
SP - 468
EP - 473
JO - BUNDESGESUNDHEITSBLA
JF - BUNDESGESUNDHEITSBLA
SN - 1436-9990
IS - 4
M1 - 4
ER -
